Evidence map›Paper›PMID 41334423›Full record

ArticleInternational journal of surgery protocols2025

From exclusion to inclusion: Analysis of patterns of follow-up in breast cancer.

N Hariharan, T S Rao, S J Rajappa, C K Naidu, B Rayani, S Kodandapani, V Koppula, D Gudipudi

Registry-linked trialAbstract read
In one paragraph

Article in International journal of surgery protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06927102 (A Comprehensive Analysis of Follow-up Outcomes, Continuity and Updated Survivorship in Breast Cancer), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06927102 recruitingnot on this map

A Comprehensive Analysis of Follow-up Outcomes, Continuity and Updated Survivorship in Breast Cancer

TypeobservationalSponsorBasavatarakam Indo American Cancer Hospital & Research InstituteRan2025 to 2025Enrolled1,500ConditionsBreast Carcinoma
3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

N HariharanDepartment of Surgical Oncology, Basavatarakam Indo American Cancer Hospital & Research Institute, Hyderabad, India.ORCID https://orcid.org/0000-0002-5976-3649
T S RaoDepartment of Surgical Oncology, Basavatarakam Indo American Cancer Hospital & Research Institute, Hyderabad, India.
S J RajappaDepartment of Medical Oncology, Basavatarakam Indo American Cancer Hospital & Research Institute, Hyderabad, India.
C K NaiduDepartment of Surgical Oncology, Basavatarakam Indo American Cancer Hospital & Research Institute, Hyderabad, India.
B RayaniDepartment of Anaesthesia, Basavatarakam Indo American Cancer Hospital & Research Institute, Hyderabad, India.
S KodandapaniDepartment of Pathology, Basavatarakam Indo American Cancer Hospital & Research Institute, Hyderabad, India.
V KoppulaDepartment of Radiology, Basavatarakam Indo American Cancer Hospital & Research Institute, Hyderabad, India.
D GudipudiDepartment of Radiation Oncology, Basavatarakam Indo American Cancer Hospital & Research Institute, Hyderabad, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Follow-up data in breast cancer is essential and forms the basis for survival metrics and key statistical measures related to morbidity and mortality. Standard practice classifies any woman who does not engage in reviews/follow-up as "lost to follow-up (LTFU)," effectively excluding her from further analysis and disregarding her data. This study aims to evaluate patterns and predictors of LTFU among women with non-metastatic breast cancer. Design: This is a single-center prospective cohort study involving women diagnosed with non-metastatic breast cancer between 2017 and 2018. The study will follow a three-phase approach. In Phase I, 5-year follow-up data will be collected retrospectively through hospital records and electronic medical records (EMRs) up to 2024. In Phase II, patients identified as LTFU will be contacted using phone, SMS, or email to assess health status and update follow-up data. Informed consent will be obtained during outreach. In Phase III, patients who respond will be asked about reasons for missed follow-up visits, including barriers related to logistics, finance, awareness, or physician advice. Data will be analyzed using descriptive statistics, logistic regression, and thematic analysis. Objectives: To determine the proportion of patients who are lost-to-follow-up at 5 years, identify factors associated with LTFU, and explore patient-reported barriers to follow-up in a public sector cancer care setting. Discussion: This study uses a mixed-methods approach, combining quantitative tracking with qualitative insights, with the aim of understanding patient retention and long-term oncology care. This study will provide real-world evidence on follow-up adherence and its determinants in a high-volume, resource-constrained oncology setting. The study is registered with ClinicalTrials.gov (Trial identifier: NCT06927102).

Indexed as

breast cancerlost-to-follow-uplow- and middle-income countries (LMICs)survivorship

Identifiers

PMID41334423
PMCPMC12668582

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.